100 Participants Needed

Studies for Stomach and Esophageal Cancer

MM
Overseen ByMeredith Mills
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore how genes and proteins contribute to the development of gastric and esophageal cancers. Researchers will study tissue and blood samples from individuals diagnosed with these cancers or those at high inherited risk. This research could lead to a better understanding and potentially new treatments for these conditions. Individuals diagnosed with gastric or esophageal cancer, or those with a family history indicating high risk, might be suitable candidates for this trial. As an unphased study, participation could provide valuable insights and contribute to future breakthroughs in cancer treatment.

Why are researchers excited about this trial?

Researchers are excited about this trial on upper gastrointestinal carcinoma because it aims to uncover new insights into the clinical and pathological aspects of this condition. Unlike treatments focusing solely on symptom management, this study investigates potential underlying mechanisms and biomarkers that could lead to more targeted therapies in the future. By exploring these pathways, the trial may pave the way for innovative approaches that offer more personalized and effective treatment options for patients.

Who Is on the Research Team?

JM

James M Ford

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

Inclusion Criteria

Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Sample Collection

Collection of tissue samples and cells from biopsies or blood samples from participants

1-2 weeks

Analysis

Study of the role genes and proteins play in the development of gastric and esophageal cancer

Ongoing

Follow-up

Participants are monitored for safety and effectiveness after sample collection

4 weeks

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security